Estadístiques de Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension
Visites totals
| views | |
|---|---|
| Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension | 3 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Shlobin_pc_pulm.pdf | 26 |
| Shlobin_pc_pulm.pdf(legacy) | 8 |
Vistes principals per país
| views | |
|---|---|
| India | 1 |
| Iran | 1 |
| United States | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Mountain View | 1 |
| Mumbai | 1 |